Inventor · disambiguated record
Nathan E. Wright
Also filed as: WRIGHT NATHAN · WRIGHT NATHAN E · WRIGHT NATHAN EDWARD
29 granted patents·21 pending applications·147 citations·filing 2011–2025
96Inventor score
Top patents by PatentIndex Score
50 records- 0198US10947259B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2020·Granted Mar 16, 2021·11 cites·4 claims
- 0297US11905299B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2021·Granted Feb 20, 2024·3 cites·3 claims
- 0397US11325930B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2021·Granted May 10, 2022·8 cites·4 claims
- 0496US11851419B2GLP-1R modulating compoundsGILEAD SCIENCES INC·Filed 2021·Granted Dec 26, 2023·7 cites·4 claims
- 0596US11702404B2GLP-1R modulating compoundsGILEAD SCIENCES INC·Filed 2020·Granted Jul 18, 2023·9 cites·3 claims
- 0696US11066414B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2019·Granted Jul 20, 2021·10 cites·9 claims
- 0795US12091404B2GLP-1R modulating compoundsGILEAD SCIENCES INC·Filed 2022·Granted Sep 17, 2024·3 cites·4 claims
- 0895US11858918B2GLP-1R modulating compoundsGILEAD SCIENCES INC·Filed 2022·Granted Jan 2, 2024·7 cites·18 claims
- 0995US9878995B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2017·Granted Jan 30, 2018·14 cites·16 claims
- 1093US10336762B2Pyrrolo[1,2-b]pyridazine derivativesGILEAD SCIENCES INC·Filed 2018·Granted Jul 2, 2019·8 cites·125 claims
- 1192US12121511B2GLP-1R modulating compoundsGILEAD SCIENCES INC·Filed 2021·Granted Oct 22, 2024·3 cites·39 claims
- 1292US11702414B2Thiadiazole IRAK4 inhibitorsGILEAD SCIENCES INC·Filed 2021·Granted Jul 18, 2023·2 cites·4 claims
- 1392US10316017B2COT modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2017·Granted Jun 11, 2019·12 cites·30 claims
- 1492US9815818B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2016·Granted Nov 14, 2017·13 cites·32 claims
- 1591US11046686B2Thiadiazole IRAK4 compoundsGILEAD SCIENCES INC·Filed 2019·Granted Jun 29, 2021·5 cites·23 claims
- 1691US10577352B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2018·Granted Mar 3, 2020·10 cites·20 claims
- 1791US10059695B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2017·Granted Aug 28, 2018·12 cites·28 claims
- 1890US11873295B2Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of diseasePETRA PHARMA CORP·Filed 2022·Granted Jan 16, 2024·3 cites·125 claims
- 1990US10875866B2Pyrrolo[1,2-B]pyridazine derivativesGILEAD SCIENCES INC·Filed 2019·Granted Dec 29, 2020·6 cites·6 claims
- 2089US12398160B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2023·Granted Aug 26, 2025·0 cites·2 claims
- 2188US2025333428A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 2286US11535622B2Pyrrolo[1,2-b] pyridazine derivativesGILEAD SCIENCES INC·Filed 2020·Granted Dec 27, 2022·1 cites·30 claims
- 2385US2025346609A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 2485US2024254137A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 2583US11827662B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2022·Granted Nov 28, 2023·0 cites·2 claims
- 2682US12415808B2Pyrrolo[1,2-b]pyridazine derivativesGILEAD SCIENCES INC·Filed 2022·Granted Sep 16, 2025·0 cites·4 claims
- 2780US12473271B2GLP-1R modulating compoundsGILEAD SCIENCES INC·Filed 2023·Granted Nov 18, 2025·0 cites·9 claims
- 2878US12497382B2GLP-1R modulating compoundsGILEAD SCIENCES INC·Filed 2023·Granted Dec 16, 2025·0 cites·10 claims
- 2976US2025084072A1Glp-1r modulating compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 3073US2021061831A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2020·Application pending·0 cites
- 3173US2022259234A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2020·Application pending·0 cites
- 3272US2025099431A1Glp-1r modulating compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 3370US2024066016A1Methods of treating nashGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 3469US2019248807A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2019·Application pending·0 cites
- 3569US2024051948A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2023·Application pending·0 cites
- 3668US12180197B2GLP-1R modulating compoundsGILEAD SCIENCES INC·Filed 2022·Granted Dec 31, 2024·0 cites·13 claims
- 3768US2024383878A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2024·Application pending·0 cites
- 3866US2018237455A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 3966US2023021705A1Glp-1r modulating compoundsGILEAD SCIENCES INC·Filed 2022·Application pending·0 cites
- 4065US12060351B2Thiadiazole IRAK4 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Aug 13, 2024·0 cites·7 claims
- 4165US2023000848A1Methods of treating nashGILEAD SCIENCES INC·Filed 2022·Application pending·0 cites
- 4263US2025312352A1Glp-1r modulating compoundsGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 4363US2023014445A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2022·Application pending·0 cites
- 4461US2017008905A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 4561US2024182460A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2023·Application pending·0 cites
- 4658US2024018115A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2023·Application pending·0 cites
- 4753US2023310663A1Method of synthesizing 18f radiolabeled biomolecular agentsUNIV ARIZONA·Filed 2023·Application pending·0 cites
- 4847US11572362B2Pyrrolo[1,2-b]pyridazine derivativesGILEAD SCIENCES INC·Filed 2019·Granted Feb 7, 2023·0 cites·10 claims
- 4947US11053250B2Pyrrolo[1,2-b]pyridazine derivativesGILEAD SCIENCES INC·Filed 2019·Granted Jul 6, 2021·0 cites·31 claims
- 5028US2014243404A1Unique halogen-induced cyclizations, reagents therefor, and compounds produced therebySNYDER SCOTT ALAN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nathan E. Wright files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →